Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes mellitus~* Men or women age ≥ 18 years old~* Stable dose combination of metformin and sulfonylurea~* HbA1c ≥7.7% and ≤11.0%~Exclusion Criteria:~* Type 1 diabetes mellitus or diabetes insipidus~* Recent cardiovascular events~* Kidney or urological disorders~* Hepatic disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dapagliflozin 10 mg tablet (Type: EXPERIMENTAL): None
- matching placebo tablet (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).